Michael Platten, MD
banner
michael-platten.bsky.social
Michael Platten, MD
@michael-platten.bsky.social
Neurologist, Chair of Neurology
Brain Tumor Immunotherapy
@dkfz.bsky.social
@platten-lab.bsky.social
@uniheidelberg.bsky.social
Medical Faculty Mannheim
Founder Tcelltech
President @eanoassociation.bsky.social
Ambassador for the @erc.europa.eu
Reposted by Michael Platten, MD
👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM

#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm
October 6, 2025 at 8:07 PM
Reposted by Michael Platten, MD
The October issue of #ScienceImmunology is out!

This month's cover highlights a Review that delves into brain tumor development and examines factors contributing to the immunosuppressive brain tumor microenvironment. Learn about this and more: https://scim.ag/46HgHcl
October 6, 2025 at 8:25 PM
The immunology of brain tumors | Science Immunology www.science.org/doi/10.1126/...

Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.
The immunology of brain tumors
The cellular and molecular determinants of the antigenicity of brain tumors and the immunosuppressive brain tumor microenvironment are reviewed.
www.science.org
October 4, 2025 at 10:49 AM
Reposted by Michael Platten, MD
🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice.
🔗 academic.oup.com/neuro-oncolo...
September 24, 2025 at 12:28 PM
Reposted by Michael Platten, MD
💡Only a few seats left for the EANO Tumor Board 2025, taking place on October 15 in Prague. Join us for interactive case-based discussions and expert insights. Registration is free for EANO members. Please register by October 3.
Learn more: www.eano.eu/eanomeetings...
September 23, 2025 at 1:00 PM
Reposted by Michael Platten, MD
Discover Neuro-Oncology Pediatrics, a new #OA journal launched by @eanoassociation.bsky.social & @neuroonc.bsky.social with editorial leadership from EANO, SNO, & ASNO, focused on advancing care for children and young adults with CNS tumors.

See the first articles: oxford.ly/4mNN1iF
August 20, 2025 at 10:00 AM
Reposted by Michael Platten, MD
📣 New journal launch! Neuro-Oncology Pediatrics is live — an open-access journal advancing global research and care for children & young adults with brain tumors.
A joint EANO & @neuroonc.bsky.social initiative.
🔗 Read more: www.eano.eu/about/news/n...
#NeuroOncology @oxfordacademic.bsky.social
August 20, 2025 at 5:33 PM
Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/
July 29, 2025 at 12:35 PM
Reposted by Michael Platten, MD
📣 Have you heard? Registration for #EANO2025, taking place Oct 16-19, 2025 in #Prague (CZ) is open! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology. Early Bird fees available until July 31, 2025. 👉 eano.eu/eano2025/reg... #braincancer #medsky
June 18, 2025 at 12:50 PM
Reposted by Michael Platten, MD
🧠 June 8 is #WorldBrainTumorDay — raising awareness & understanding of brain tumors.
EANO supports progress in #NeuroOncology through research, education & collaboration.
🔗 Learn more: www.eano.eu
#btsm #BrainTumor #Oncology
June 8, 2025 at 9:44 AM
Reposted by Michael Platten, MD
Wissenschaft braucht verlässliche Infrastrukturen - viele davon liegen noch in den USA. Der WR-Vorsitzende
@wickwolfgang.bsky.social fordert in der @faznet.bsky.social eine europäische Strategie für mehr Unabhängigkeit👉 www.faz.net/aktuell/wiss...
#DigitaleSouveränität #Forschung #Infrastruktur
June 4, 2025 at 10:27 AM
Reposted by Michael Platten, MD
Join us this week on Thursday (22nd May) for our next i2 seminar! This week it’s all about T cells in cancer!
May 19, 2025 at 6:23 AM
Reposted by Michael Platten, MD
The organizing committee of the UNITE conference would like to thank all speakers for their excellent presentations and all participants for the valuable discussions. @wickwolfgang.bsky.social @michael-platten.bsky.social
May 15, 2025 at 2:08 PM
Reposted by Michael Platten, MD
🧠 Join the next #EANOYoungsters Journal Club on June 5, 16:30–17:30 CEST!
Discussing: "Rapid molecular profiling of CNS tumors" www.nature.com/articles/s41... (Patel et al., Nat Med 2025)
📍Free & open to all EANO members
🔗 www.eano.eu
#NeuroOncology #BrainTumors #JournalClub
May 15, 2025 at 9:45 AM
Reposted by Michael Platten, MD
The second day of the UNITE conference. Today there will also be a contribution from a patient on the book “Alles gut? Alles gut.” by Marlene Assmann. www.jacobystuart.de/buecher-von-...
May 15, 2025 at 8:36 AM
Reposted by Michael Platten, MD
The SynthImmune project by Heidelberg University& partner institutes advances a "bottom-up" synthetic biology approach to immunotherapies.
Hoping they do well in the German government's Excellence Strategy—anticipating the announcement on 22 May.

Perspective article: www.nature.com/articles/s41...
Bottom-up synthetic immunology - Nature Nanotechnology
This Perspective highlights bottom-up molecular engineering and modular nanobiotechnological approaches for developing effective immunotherapeutics and their potential in personalized medicine.
www.nature.com
May 14, 2025 at 7:38 AM
Reposted by Michael Platten, MD
⏱️ Clock is ticking! Final call for abstract submissions for #EANO2025 in #Prague. Don't miss this chance to share your work contribute to the advancement of #NeuroOncology. Submit now via our official event website: www.eano.eu/eano2025/ until May 6, 2025, 23.59 CEST!
@oncoalert.bsky.social
May 6, 2025 at 11:58 AM
Reposted by Michael Platten, MD
Wir freuen uns, die UNITE-Glioblastom-Konferenz ankündigen zu können, die am 14. und 15. Mai 2025 im DKFZ-Kommunikationszentrum in Heidelberg stattfinden wird. melden Sie sich heute an: www.unite-glioblastoma.de/unite-confer...
UNITE CONFERENCE - UNITE Glioblastoma
Conference
www.unite-glioblastoma.de
May 2, 2025 at 9:08 AM
Reposted by Michael Platten, MD
🚀 We are proud to launch the new "Ambassadors for the ERC" initiative, together with @ercgrantees.bsky.social !

We aim to empower researchers across Europe to advocate for frontier research. Find out more 👉 bit.ly/44bQzp7

🌟 Excited to see what can be achieved!

#Amb4ERC
April 29, 2025 at 7:01 AM
Reposted by Michael Platten, MD
@michael-platten.bsky.social has been selected and nominated as Ambassador for the ERC network. The @erc.europa.eu & the @ercgrantees.bsky.social launched the new Ambassadors on 28 April. This joint initiative aims to promote investment in frontier research and highlight the importance of #research.
April 30, 2025 at 10:54 AM
Reposted by Michael Platten, MD
🗓️ Only one week to go! The abstract submission deadline for #EANO2025 in #Prague is approaching fast. This is your opportunity to share your findings, collaborate with peers, and be recognized in the field of #NeuroOncology. Submit your abstract now: www.eano.eu/eano2025/ #btsm
April 23, 2025 at 9:16 PM
Reposted by Michael Platten, MD
Do you want to do your #postdoc in #cancerresearch with the most prestigious #fellowship in Europe? Apply to DKFZ Marie Skłodowska Curie MasterClasses by May 19. Projects in #cellandmolecularbiology #genomics #bioinformatics #immunology #medicaltechnology, #epidemiology.
Apply here: t1p.de/nx6tu
April 22, 2025 at 1:50 PM
Reposted by Michael Platten, MD
🚀 New publication! We developed a PTPRZ1-specific TCR-T cell therapy for glioblastoma.

🔬 Key findings:
✅ Identified a PTPRZ1-reactive TCR from a vaccinated patient
✅ Kills glioblastoma cells with no off-target effects
✅ Eliminates tumors in murine brain models

🔗 www.nature.com/articles/s41...
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen - Nature Communications
Vaccination in glioblastomas does lead to the emergence of tumour-antigen-specific T cells but T cell dysfunction, poor tumour infiltration and persistence hinder efficient tumour killing. Here author...
www.nature.com
February 11, 2025 at 11:29 AM
Reposted by Michael Platten, MD
Don’t miss our i2 seminar today at 4 pm where we will hear more about immunogenic cancer editopes and the lineage tree of tissue macrophage development.
Join us for a lively discussion and snacks and drinks! 🧪
Today at 4pm in the main building 👇
The i2 seminars are back on Thursday, April 17, at 4 pm with two talks by Dr. Bea Casati, Postdoc in the Papavasiliou Lab, and Larissa Frank, PhD student in the Rodewald Lab. Save the date and join us for a lively discussion!
@dkfz.bsky.social
@beacasati.bsky.social
@larissafrank.bsky.social
April 17, 2025 at 8:27 AM